Clinical Trial Update: A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial investigates the safety and preliminary effectiveness of AZD9750 in metastatic prostate cancer, with no recruitment yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AZD9750

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING